GET https://spineway.asb-digital.fr/en/sitemap

Translation

en Default locale
en Fallback locale

Messages

Defined 72

These messages are correctly translated into the given locale.

Locale Domain Times used Message ID Message Preview
en messages 1 external_redirect_popup.title External redirection
en messages 2 external_redirect_popup.text You are about to be redirected to %url%. Do you want to continue?
en messages 1 external_redirect_popup.no Cancel
en messages 1 external_redirect_popup.yes Continue
en header 1 nav.about About us
en header 1 nav.products Products
en header 4 nav.seeall See all products
en header 1 nav.articles News
en header 7 no-item.message No product available in your country for now.<br>Please contact us for more information
en header 7 no-item.contact Contact us
en header 1 nav.jobOffers Careers
en header 1 nav.investors Investors
en header 1 nav.investors_schedule Schedule
en header 1 nav.investors_shares Share price
en header 1 nav.investors_regulated_info Regulated informations
en header 1 nav.investors_press_release Press releases
en header 1 nav.contact Contact
en header 1 Education Education
en header 1 Private Access Private Access
en header 1 nav.language Select your language
en sitemap 2 sitemap.title Site map
en sitemap 1 static.title Various pages
en sitemap 1 static.homepage Homepage
en sitemap 1 static.confidentiality Confidentiality
en sitemap 1 static.legal_terms Legal Information
en sitemap 1 static.about About us
en sitemap 1 investors.title Investors
en sitemap 1 investors.schedule Shedule
en sitemap 1 investors.shares Share price
en sitemap 1 investors.info Regulated Information
en sitemap 1 job_offers.title Career
en sitemap 1 job_offers.all All job offers
en sitemap 1 articles.title Articles
en sitemap 1 articles.all All articles
en sitemap 1 products.title Products
en sitemap 1 products.all All products
en footer 1 support.title Access to Web Support - Spineway
en footer 1 support.text Access the private area of our website, reserved exclusively for our customers. You will find all the documents related to our products.
en footer 1 support.button Private Access
en footer 1 footer_contact.textbold Contact us for more information
en footer 1 footer_contact.textreg on SPINEWAY products
en footer 2 links.contact Contact
en footer 1 logo.disclaimer Spineway designs and delivers innovative spinal implants and instruments, improving spinal surgery worldwide for 20 years.
en footer 1 links.products Products
en footer 1 links.posterior_fixation Posterior Fixation
en footer 1 links.interbody_fusion Interbody Fusion
en footer 1 links.motion_preservation Motion Preservation
en footer 1 links.biomaterials Biomaterials
en footer 1 links.spineway_group Spineway Group
en footer 1 links.about About us
en footer 1 links.education Education
en footer 1 links.news News
en footer 1 links.events Events
en footer 1 links.press_releases Press Releases
en footer 1 links.blog Blog
en footer 1 links.investors Investors
en footer 1 links.schedule Schedule
en footer 1 links.share_price Share Price
en footer 1 links.regulated_information Regulated information
en footer 1 links.career Careers
en footer 1 links.informations Informations
en footer 1 bottom_links.app_legal_terms_new Legal terms
en footer 1 bottom_links.app_sitemap_new Sitemap
en footer 1 bottom_links.app_confidentiality_new Privacy policy
en footer 1 cookies.preferences Cookies preferences
en footer 1 footer.allrights All rights reserved
en footer 1 asb_disclaimer Made with <svg class="heart" width="12" height="12" viewBox="0 0 12 12" fill="none" xmlns="http://www.w3.org/2000/svg"> <g clip-path="url(#clip0_994_1158)"> <path d="M10.8352 1.46723C9.55082 0.372702 7.64067 0.569577 6.46176 1.78598L6.00004 2.26176L5.53832 1.78598C4.36176 0.569577 2.44926 0.372702 1.16489 1.46723C-0.306988 2.72348 -0.384332 4.97817 0.932856 6.33989L5.46801 11.0227C5.76098 11.325 6.23676 11.325 6.52973 11.0227L11.0649 6.33989C12.3844 4.97817 12.3071 2.72348 10.8352 1.46723Z" fill="#2D7DBE"/> </g> <defs> <clipPath id="clip0_994_1158"> <rect width="12" height="12" fill="white"/> </clipPath> </defs> </svg> by ASB DIGITAL
en messages 1 loader.text LOADING
en messages 1 popup.title Intended for healthcare professionals
en messages 1 popup.text The information provided on the following pages is exclusively intended for healthcare professionals. By clicking here you certify being a healthcare professional.
en messages 1 popup.no NO
en messages 1 popup.yes Yes, let me in

Fallback 0

These messages are not available for the given locale but Symfony found them in the fallback locale catalog.

No fallback translation messages were used.

Missing 124

These messages are not available for the given locale and cannot be found in the fallback locales. Add them to the translation catalogue to avoid Symfony outputting untranslated contents.

Locale Domain Times used Message ID Message Preview
en header 1 Posterior Fixation Posterior Fixation
en header 2 Posterior osteosynthesis system MONT BLANC Posterior osteosynthesis system MONT BLANC
en header 2 Minimal invasive posterior osteosynthesis system MONT BLANC MIS Minimal invasive posterior osteosynthesis system MONT BLANC MIS
en header 2 Side-loading posterior osteosynthesis system KAPHORN Side-loading posterior osteosynthesis system KAPHORN
en header 2 Posterior semi-rigid osteosynthesis system VEOS PEEK-OPTIMA™ Image Contrast Posterior semi-rigid osteosynthesis system VEOS PEEK-OPTIMA™ Image Contrast
en header 2 Posterior osteosynthesis system VEOS TITANIUM Posterior osteosynthesis system VEOS TITANIUM
en header 1 Interbody Fusion Interbody Fusion
en header 2 Cervical cage ACIFBOX Cervical cage ACIFBOX
en header 2 Cervical plate ACIFBOX Cervical plate ACIFBOX
en header 2 Cervical plate-cage ACIFBOX Cervical plate-cage ACIFBOX
en header 2 Secured Cervical cage ACIFBOX Secured Cervical cage ACIFBOX
en header 2 Stand alone cervical cage ACIFBOXd Stand alone cervical cage ACIFBOXd
en header 2 Lumbar cage TWIN PEAKS TLIF CURVED Lumbar cage TWIN PEAKS TLIF CURVED
en header 2 Lumbar cage TWIN PEAKS TLIF OBLIQUE Lumbar cage TWIN PEAKS TLIF OBLIQUE
en header 1 Motion preservation Motion preservation
en header 2 Lumbar prosthesis LP-ESP Lumbar prosthesis LP-ESP
en header 2 Cervical prosthesis CP-ESP Cervical prosthesis CP-ESP
en header 1 Biomaterials Biomaterials
en header 2 Hydroxyapatite nanoparticle gel NEVE Hydroxyapatite nanoparticle gel NEVE
en header 1 Events Events
en header 1 Press releases Press releases
en header 1 Blog Blog
en sitemap 1 VIE H/F EUROPE (01/2025) VIE H/F EUROPE (01/2025)
en sitemap 1 Stagiaire Chargé(e) Affaires Cliniques F/H Stagiaire Chargé(e) Affaires Cliniques F/H
en sitemap 1 WHX Dubai 2026 (formerly Arab Health) WHX Dubai 2026 (formerly Arab Health)
en sitemap 1 azed azed
en sitemap 1 Preview Test Preview Test
en sitemap 1 The 3 functions of the spine The 3 functions of the spine
en sitemap 1 The vertebrae The vertebrae
en sitemap 1 Titre de mon actualité - type Event (one date) EN Titre de mon actualité - type Event (one date) EN
en sitemap 1 Titre de mon actualité - type Event (date à date) Titre de mon actualité - type Event (date à date)
en sitemap 1 Half-year results 2024 Half-year results 2024
en sitemap 1 Great success at the 24th AMCICO Congress in Mexico Great success at the 24th AMCICO Congress in Mexico
en sitemap 1 Spineway a Gold Sponsor at the SILACO Congress in Mexico – Organization of a special event with Latin American distributors Spineway a Gold Sponsor at the SILACO Congress in Mexico – Organization of a special event with Latin American distributors
en sitemap 1 First-half 2024 revenue of €6.5 million, organic growth of 20% First-half 2024 revenue of €6.5 million, organic growth of 20%
en sitemap 1 Spineway organizes hands-on training on total disc replacement with its ESP prostheses at IRCAD in Strasbourg Spineway organizes hands-on training on total disc replacement with its ESP prostheses at IRCAD in Strasbourg
en sitemap 1 Spineway continues its sales and marketing efforts in Europe Spineway continues its sales and marketing efforts in Europe
en sitemap 1 Hands-on surgical training in Hong Kong at the SMISS Asia Pacific 2024 Congress Hands-on surgical training in Hong Kong at the SMISS Asia Pacific 2024 Congress
en sitemap 1 Presentation of the KAPHORN system to 200 surgeons at the SOTCOT Congress in Hammamet Presentation of the KAPHORN system to 200 surgeons at the SOTCOT Congress in Hammamet
en sitemap 1 SPINEWAY partners with the SFCR Congress in Montpellier, France SPINEWAY partners with the SFCR Congress in Montpellier, France
en sitemap 1 SPINEWAY organizes surgical training sessions in the use of ESP and KAPHORN implants SPINEWAY organizes surgical training sessions in the use of ESP and KAPHORN implants
en sitemap 1 First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter First-quarter 2024 revenue of €3.1 million Growth of 28% compared with 2023 first quarter
en sitemap 1 Minutes of the General Meeting of March 25, 2024 Minutes of the General Meeting of March 25, 2024
en sitemap 2 Effective date of the Spineway reverse stock split Effective date of the Spineway reverse stock split
en sitemap 1 Combined General Meeting of March 25, 2024 Availability of preparatory documents Combined General Meeting of March 25, 2024 Availability of preparatory documents
en sitemap 1 2023 annual results 2023 annual results
en sitemap 1 2023 revenue of €10.5 million 2023 revenue of €10.5 million
en sitemap 1 Reverse split of Spineway shares Reverse split of Spineway shares
en sitemap 1 International rollout of the VEOS implant range International rollout of the VEOS implant range
en sitemap 1 Minutes of the General Meeting of November 10, 2023 Minutes of the General Meeting of November 10, 2023
en sitemap 1 Appointment of Sandrine Carle as Deputy Chief Executive Officer Appointment of Sandrine Carle as Deputy Chief Executive Officer
en sitemap 1 VEOS system well perceived at the NASS 2023 conference in the United States / Sales growth in France VEOS system well perceived at the NASS 2023 conference in the United States / Sales growth in France
en sitemap 1 Spineway obtains 510(k) clearance from the FDA for its VEOS spinal fixation system Spineway obtains 510(k) clearance from the FDA for its VEOS spinal fixation system
en sitemap 1 9-month revenue up 40% at €7.5 million 9-month revenue up 40% at €7.5 million
en sitemap 1 H1 2023 results H1 2023 results
en sitemap 1 Spineway organizes an international masterclass with expert spine surgeons Spineway organizes an international masterclass with expert spine surgeons
en sitemap 1 First-half 2023 revenue of €5.4 million (+75%) First-half 2023 revenue of €5.4 million (+75%)
en sitemap 1 Strengthening of the cash position in support of the Group’s developments Strengthening of the cash position in support of the Group’s developments
en sitemap 1 First-quarter 2023 revenue of €2.4 million (+79%) First-quarter 2023 revenue of €2.4 million (+79%)
en sitemap 1 Report on Spineway’s Combined General Meeting of April 4, 2023 Report on Spineway’s Combined General Meeting of April 4, 2023
en sitemap 1 Combined General Meeting of April 4, 2023 – Availability of preparatory documents Combined General Meeting of April 4, 2023 – Availability of preparatory documents
en sitemap 1 2022 annual results 2022 annual results
en sitemap 1 Spineway 2023 Financial Calendar Spineway 2023 Financial Calendar
en sitemap 1 2022 revenues up 73% to €7.4 million 2022 revenues up 73% to €7.4 million
en sitemap 1 Remarkable participation at 2022 Eurospine congress in Milan Remarkable participation at 2022 Eurospine congress in Milan
en sitemap 1 Nine-month turnover of €5.4 million, up 82% Nine-month turnover of €5.4 million, up 82%
en sitemap 1 Spineway participates to the Lyon Pôle Bourse Forum Spineway participates to the Lyon Pôle Bourse Forum
en sitemap 1 Half-year results 2022 Half-year results 2022
en sitemap 1 Launch of a Spineway share consolidation Launch of a Spineway share consolidation
en sitemap 1 Continuation of the targeted external growth strategy – Acquisition of Spine Innovations Continuation of the targeted external growth strategy – Acquisition of Spine Innovations
en sitemap 1 Revenue for the first half 2022 : + 65% Revenue for the first half 2022 : + 65%
en sitemap 1 New momentum for a strong comeback on the French market New momentum for a strong comeback on the French market
en sitemap 1 Continued growth in Q1 2022 Q1 2022 revenues up +55% Continued growth in Q1 2022 Q1 2022 revenues up +55%
en sitemap 1 2nd invitation to the Combined General Meeting on 11 April 2022 2nd invitation to the Combined General Meeting on 11 April 2022
en sitemap 1 Combined General Meeting of March 23, 2022 Combined General Meeting of March 23, 2022
en sitemap 1 2021 annual results 2021 annual results
en sitemap 1 2021 revenue 2021 revenue
en sitemap 1 Revenue as of September 2021 (9 months): +27% Revenue as of September 2021 (9 months): +27%
en sitemap 1 Improvements of 2021 half-year results Improvements of 2021 half-year results
en sitemap 1 2021 Half Year Results postponed 2021 Half Year Results postponed
en sitemap 1 Revenue for the first half of 2021: +30% Revenue for the first half of 2021: +30%
en sitemap 1 Acquisition of the company Distimp confirmed Acquisition of the company Distimp confirmed
en sitemap 1 Signature of a Memorandum of Understanding for the acquisition of the Distimp start-up Signature of a Memorandum of Understanding for the acquisition of the Distimp start-up
en sitemap 1 Universal Registration Document available Universal Registration Document available
en sitemap 1 Q1 2021 turnover Q1 2021 turnover
en sitemap 1 Continued International Development Continued International Development
en sitemap 1 Exclusive negotiations for the acquisition of a start-up in the field of spinal surgery Exclusive negotiations for the acquisition of a start-up in the field of spinal surgery
en sitemap 1 Approval of the General Meeting’s resolutions Solid cash position to continue development Approval of the General Meeting’s resolutions Solid cash position to continue development
en sitemap 1 Signature of a partnership with Tsunami Medical Signature of a partnership with Tsunami Medical
en sitemap 1 Continued expansion in Asia Continued expansion in Asia
en sitemap 1 January 25 2021 2020 annual results January 25 2021 2020 annual results
en sitemap 1 January 21 2021 2020 revenue January 21 2021 2020 revenue
en sitemap 1 January 8 2021 2021 Financial calendar January 8 2021 2021 Financial calendar
en sitemap 1 December 23 2020 Financing Plan – New tranche of Negma Convertible Bonds December 23 2020 Financing Plan – New tranche of Negma Convertible Bonds
en sitemap 1 December 21 2020 Spineway selects TUV Rheinland for certification of its products December 21 2020 Spineway selects TUV Rheinland for certification of its products
en sitemap 1 October 27 2020 – 2020 half-year results October 27 2020 – 2020 half-year results
en sitemap 1 September 9 2020 Launch of MISTI, a modular platform for instruments September 9 2020 Launch of MISTI, a modular platform for instruments
en sitemap 1 July 23 2020 Publication of a clinical study on the advantages of Mont-Blanc 3D+ in the treatment of scoliosis July 23 2020 Publication of a clinical study on the advantages of Mont-Blanc 3D+ in the treatment of scoliosis
en sitemap 1 July 9 2020 Revenue for the first half of 2020 July 9 2020 Revenue for the first half of 2020
en sitemap 1 May 29 2020 Minutes of the Extraordinary and Ordinary General Shareholders’ Meeting of 26 May 2020 Capital decrease May 29 2020 Minutes of the Extraordinary and Ordinary General Shareholders’ Meeting of 26 May 2020 Capital decrease
en sitemap 1 May 23 2020 Government-backed loan of €1.13M secured / Reserved capital increase of €4.6M implemented May 23 2020 Government-backed loan of €1.13M secured / Reserved capital increase of €4.6M implemented
en sitemap 1 April 23 2020 Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments April 23 2020 Signature of an exclusive agreement with the Japanese distributor MURANAKA Medical Instruments
en sitemap 1 April 16 2020 2019 annual results April 16 2020 2019 annual results
en sitemap 1 January 16 2020 2019 : a year of restructuring 2019 revenue of €5M January 16 2020 2019 : a year of restructuring 2019 revenue of €5M
en sitemap 1 January 29 2020 Appointment of Myriam Denis-Galland as Chief Financial Officer January 29 2020 Appointment of Myriam Denis-Galland as Chief Financial Officer
en sitemap 1 Posterior Fixation Posterior Fixation
en sitemap 1 Posterior osteosynthesis system MONT BLANC Posterior osteosynthesis system MONT BLANC
en sitemap 1 Minimal invasive posterior osteosynthesis system MONT BLANC MIS Minimal invasive posterior osteosynthesis system MONT BLANC MIS
en sitemap 1 Side-loading posterior osteosynthesis system KAPHORN Side-loading posterior osteosynthesis system KAPHORN
en sitemap 1 Posterior semi-rigid osteosynthesis system VEOS PEEK-OPTIMA™ Image Contrast Posterior semi-rigid osteosynthesis system VEOS PEEK-OPTIMA™ Image Contrast
en sitemap 1 Posterior osteosynthesis system VEOS TITANIUM Posterior osteosynthesis system VEOS TITANIUM
en sitemap 1 Interbody Fusion Interbody Fusion
en sitemap 1 Cervical cage ACIFBOX Cervical cage ACIFBOX
en sitemap 1 Cervical plate ACIFBOX Cervical plate ACIFBOX
en sitemap 1 Cervical plate-cage ACIFBOX Cervical plate-cage ACIFBOX
en sitemap 1 Secured Cervical cage ACIFBOX Secured Cervical cage ACIFBOX
en sitemap 1 Stand alone cervical cage ACIFBOXd Stand alone cervical cage ACIFBOXd
en sitemap 1 Lumbar cage TWIN PEAKS TLIF CURVED Lumbar cage TWIN PEAKS TLIF CURVED
en sitemap 1 Lumbar cage TWIN PEAKS TLIF OBLIQUE Lumbar cage TWIN PEAKS TLIF OBLIQUE
en sitemap 1 Motion preservation Motion preservation
en sitemap 1 Lumbar prosthesis LP-ESP Lumbar prosthesis LP-ESP
en sitemap 1 Cervical prosthesis CP-ESP Cervical prosthesis CP-ESP
en sitemap 1 Biomaterials Biomaterials
en sitemap 1 Hydroxyapatite nanoparticle gel NEVE Hydroxyapatite nanoparticle gel NEVE